SAN DIEGO, — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced preliminary highlights of the Company’s 2012 performance and accomplishments. Initial 2012 Performance Results (unaudited) Total revenue of approximately $89 million, growth of approximately 59 percent year-over-year for 2012 Diagnostic services revenues of approximately $46 […]
Milford, Massachusetts, – SeraCare Life Sciences, a portfolio company of Linden Capital Partners serving the in vitro diagnostics and clinical laboratory markets, today announced that it has sold its biorepository, biobanking and laboratory services business to Precision Health Holdings, Inc. This Maryland-based business includes biorepository and biobanking services, AccuCell® products and certain laboratory services. “The […]
Hamburg, Germany – Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced the acquisition of all shares in Cell Culture Service GmbH (CCS), a Hamburg-based company which supports the cell culture needs of a world-wide customer base of biotech and Pharmaceutical companies. CCS is one of the leading suppliers of custom cells and cell-based reagents […]
Hannover / Germany, – ZELLKRAFTWERK today announced the start of its early technology access program for ChipcytometryTM, a groundbreaking high-content cytometry technology for cellular biomarker discovery and bioanalysis. ChipcytometryTM allows for sample storage and biomarker preservation for about 12 month and enables iterative re-analysis of the same sample with different marker-sets for several times. In […]
MADISON, WIS.,– Cellular Dynamics International, Inc. (CDI) today announced a Center of Excellence agreement with AstraZeneca to accelerate the pace of drug discovery through the use of human induced pluripotent stem cell (iPSC) lines and tissue cells. iPSC technology, based on reprogramming adult cells from a simple blood sample or a skin biopsy to a […]
EMERYVILLE, Calif.– Omicia, Inc., a privately held company offering integrated solutions for interpreting human genome sequences, today announced the appointment of Mike Aicher as Chief Executive Officer and member of the company’s Board of Directors. “Martin and the outstanding Omicia team have built a truly ground-breaking genome interpretation platform with the highest levels of scientific […]
AMSBIO has announced the launch of the 3D Culture 96-Well BME* Cell Invasion Assay to address the growing need for more complete and physiologically predictive cancer invasion models. Invasive migration is a fundamental function underlying cellular processes such as angiogenesis, embryonic development, immune response, metastasis, and invasion of cancer cells. AMSBIO’s new 3D Culture 96-Well […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche’s portfolio of next-generation sequencing platforms. It is intended to support Roche’s GS Junior and GS FLX+ systems as well as the sequencing […]
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Corning, Inc.’s proposed acquisition of Becton, Dickinson and Company’s Discovery Labware Division would have been anticompetitive in the North American markets for tissue culture treated (TCT) multi-well plates, dishes, and flasks used in cell culture applications. Under the […]
ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT: BTX) today announced the appointment of Jeffrey Janus as its Vice President of Sales and Marketing. Mr. Janus’ primary focus will be to create, market, and sell research products for BioTime and its subsidiaries in the expanding field of regenerative medicine. Mr. Janus has more than 25 years […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
